Market open

CASI Pharmaceuticals Inc./$CASI

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Ticker

$CASI
Trading on

Industry

Biotechnology
Headquarters

Employees

233

CASI Metrics

BasicAdvanced
$30M
-
-$2.56
0.61
-
$30M
0.61
$2.52
$1.88
13K
1.086
0.862
136.953
1,196.164
-45.02%
-38.01%
-301.80%
1.032
16.07
18.44
-1.017
-15.77%
26.73%
-1.84%
-1.68%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CASI

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs

What’s the current market cap for CASI Pharmaceuticals Inc. stock?

CASI Pharmaceuticals Inc. (CASI) has a market cap of $30M as of April 22, 2025.

What is the P/E ratio for CASI Pharmaceuticals Inc. stock?

The price to earnings (P/E) ratio for CASI Pharmaceuticals Inc. (CASI) stock is 0 as of April 22, 2025.

Does CASI Pharmaceuticals Inc. stock pay dividends?

No, CASI Pharmaceuticals Inc. (CASI) stock does not pay dividends to its shareholders as of April 22, 2025.

When is the next CASI Pharmaceuticals Inc. dividend payment date?

CASI Pharmaceuticals Inc. (CASI) stock does not pay dividends to its shareholders.

What is the beta indicator for CASI Pharmaceuticals Inc.?

CASI Pharmaceuticals Inc. (CASI) has a beta rating of 0.61. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.